Results 201 to 210 of about 281,748 (215)
Some of the next articles are maybe not open access.

Rusfertide, a Hepcidin Mimetic, for Control of Erythrocytosis in Polycythemia Vera.

New England Journal of Medicine
BACKGROUND Polycythemia vera is a chronic myeloproliferative neoplasm characterized by erythrocytosis. Rusfertide, an injectable peptide mimetic of the master iron regulatory hormone hepcidin, restricts the availability of iron for erythropoiesis.
M. Kremyanskaya   +18 more
semanticscholar   +1 more source

Efficacy and safety of ropeginterferon alfa-2b in Japanese patients with polycythemia vera: an open-label, single-arm, phase 2 study

International journal of hematology, 2022
Y. Edahiro   +16 more
semanticscholar   +1 more source

Advances in Understanding and Management of Myeloproliferative Neoplasms

Ca-A Cancer Journal for Clinicians, 2009
Paola Guglielmelli
exaly  

Cardiovascular Events and Intensity of Treatment in Polycythemia Vera

New England Journal of Medicine, 2013
Roberto Marchioli   +2 more
exaly  

Macrophages support pathological erythropoiesis in polycythemia vera and β-thalassemia

Nature Medicine, 2013
Carla Casu, Sara Gardenghi, Laura Breda
exaly  

Myeloproliferative neoplasms: contemporary diagnosis using histology and genetics

Nature Reviews Clinical Oncology, 2009
Ayalew Tefferi
exaly  

Disruption of oxygen homeostasis underlies congenital Chuvash polycythemia

Nature Genetics, 2002
Kiichi Hirota   +2 more
exaly  

A clinical-molecular prognostic model to predict survival in patients with post polycythemia vera and post essential thrombocythemia myelofibrosis

Leukemia, 2017
F. Passamonti   +26 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy